Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel in Bipolar Depression (BOLDER I)
NCT00060489Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started Sep 2002; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00060489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060489.